Release Testing
Coriolis Pharma offers GMP release testing services to ensure your drug products meet the highest quality, safety and efficacy standards before reaching the clinic or the market. Our scientific expertise and advanced technologies guarantee reliable and accurate testing, supporting your regulatory compliance and product release requirements.
Release Testing Tailored to Your Needs
We provide tailored release testing strategies to meet the specific needs of your drug product, ensuring it adheres to stringent quality control standards and regulatory requirements.
Our comprehensive release testing services include:
Identity Testing
Confirming the identity of the active pharmaceutical ingredient (API) and other key components.
Purity Testing
Assessing the purity of the products and detecting any impurities or related substances.
Potency & Bioactivity
Determining the concentration and potency of the active ingredient.
Physical Testing
Physical testing includes appearance, color, clarity, osmolality, moisture content and subvisible particles/particulate matter.
Specific Tests
Specific tests include peptide mapping, aggregation (by analytical ultracentrifugation or high-performance size-exclusion chromatography) and charge variants (by capillary gel electrophoresis or exchange chromatography).
Surfactant Analysis
Quantitative and qualitative analysis of surfactants.
Visual Inspection
Ensuring the appearance of the drug product meets specified standards.
Release Testing Methods
We can select the most suitable approach for your analytical challenge, whether following a standardized in-house workflow or a custom-tailored solution.
Analytical Method Development, Qualification and Validation
For common sample types, we can often apply standardized methods with little setup effort. However, when needed, our experienced analytical experts create or optimize custom methods tailored to your active pharmaceutical ingredient, product type and development phase.
Release Testing for Your Drug Product
Coriolis Pharma’s deep expertise across many biologic modalities for drug product–specific release testing under GMP conditions ensures reliable testing results of your clinical or commercial drug product. We offer those services in close collaboration with our clients or their CDMOs. We are open to being an integral part of quality control/qualified person (QC/QP) release testing of CDMOs. We are regularly audited by our clients and inspected by our responsible authority.
Your Phase
Our expert team has the expertise and experience to guide your drug product development program from preclinical and early-phase development to the market.
Release Testing Resources
Publications
October 8, 2024
Publications
April 12, 2024
Publications
April 1, 2024